Showing results (71-80 of 156) with videos related to
Sort By:
Pageof 16
Molecular Immunology|February 11, 2009
Autologous T cell depleted haematopoietic stem cell transplantation in children with severe juvenile idiopathic arthritis in the UK (2000-2007)Mario Abinun, Terence J Flood, Andrew J Cant, et al.Proceedings of the National Academy of Sciences of the United States of America|March 2, 2019
Human cytomegalovirus haplotype reconstruction reveals high diversity due to superinfection and evidence of within-host recombinationJuliana Cudini, Sunando Roy, Charlotte J Houldcroft, et al.Blood|February 18, 2011
Treosulfan-based conditioning regimens for hematopoietic stem cell transplantation in children with primary immunodeficiency: United Kingdom experienceMary A Slatter, Kanchan Rao, Persis Amrolia, et al.British Journal of Haematology|April 27, 2012
Haematopoietic stem cell transplantation (HSCT) in severe autoimmune diseases: analysis of UK outcomes from the British Society of Blood and Marrow Transplantation (BSBMT) data registry 1997-2009John A Snowden, Rachel M Pearce, Julia Lee, et al.Journal of Clinical Immunology|February 10, 2015
Variable phenotype of severe immunodeficiencies associated with RMRP gene mutationsWinnie Ip, H Bobby Gaspar, Robert Kleta, et al.Blood|February 4, 2017
Brincidofovir is highly efficacious in controlling adenoviremia in pediatric recipients of hematopoietic cell transplantPrashant Hiwarkar, Persis Amrolia, Ponni Sivaprakasam, et al.Blood Advances|January 4, 2018
Use of the complement inhibitor Coversin to treat HSCT-associated TMATimothy H J Goodship, Fernando Pinto, Wynn H Weston-Davies, et al.Frontiers in Microbiology|September 27, 2016
Detection of Low Frequency Multi-Drug Resistance and Novel Putative Maribavir Resistance in Immunocompromised Pediatric Patients with CytomegalovirusCharlotte J Houldcroft, Josephine M Bryant, Daniel P Depledge, et al.Frontiers in Immunology|July 29, 2022
Epstein-Barr Virus Reactivation After Paediatric Haematopoietic Stem Cell Transplantation: Risk Factors and Sensitivity Analysis of Mathematical ModelSoumya P Kania, Juliana M F Silva, Oscar J Charles, et al.Cytotherapy|May 14, 2018
Multicenter phase 1/2 application of adenovirus-specific T cells in high-risk pediatric patients after allogeneic stem cell transplantationWinnie Ip, Juliana M F Silva, Hubert Gaspar, et al.Pageof 16